Table 3.

Summary of 21-day outcomes among participants with indeterminate diagnosis (IND). Each column represents the distribution of the 21-day outcome, overall or within a certain subgroup. The distribution of the 21-day outcome are significantly different across the five latent subgroups (p<.001).

	All N=380	Subgroup1 N=59	Subgroup2 N=57	Subgroup3 N=48	Subgroup4 N=130	Subgroup5 N=86
21-day Outcome*	N=379	N=58	N=57	N=48	N=130	N=86
Death by day 7	14(4%)	0(0%)	2(4%)	1(2%)	3(2%)	8(9%)
LTx by day 7	110(29%)	0(0%)	2(4%)	13(27%)	36(28%)	59(69%)
Death between day 8–21	19(5%)	3(5%)	0(0%)	1(2%)	9(7%)	6(7%)
LTx between day 8–21	41(11%)	0(0%)	0(0%)	1(2%)	30(23%)	10(12%)
Alive with native liver at day 21	195(52%)	55(95%)	53(93%)	32(67%)	52(40%)	3(3%)
Total death by day 21	33 (9%)	3(5%)	2(4%)	2(4%)	12(9%)	14(16%)
Total LTx by day 21	151(40%)	0(0%)	2(4%)	14(29%)	66(51%)	69(80%)